Journal article
Genetic modifiers of CHEK2∗1100delC-associated breast cancer risk
TA Muranen, D Greco, C Blomqvist, K Aittomäki, S Khan, F Hogervorst, S Verhoef, PDP Pharoah, AM Dunning, M Shah, R Luben, SE Bojesen, BG Nordestgaard, M Schoemaker, A Swerdlow, M García-Closas, J Figueroa, T Dörk, NV Bogdanova, P Hall Show all
Genetics in Medicine | NATURE PUBLISHING GROUP | Published : 2017
DOI: 10.1038/gim.2016.147
Abstract
Purpose:CHEK2∗1100delC is a founder variant in European populations that confers a two- to threefold increased risk of breast cancer (BC). Epidemiologic and family studies have suggested that the risk associated with CHEK2∗1100delC is modified by other genetic factors in a multiplicative fashion. We have investigated this empirically using data from the Breast Cancer Association Consortium (BCAC).Methods:Using genotype data from 39,139 (624 1100delC carriers) BC patients and 40,063 (224) healthy controls from 32 BCAC studies, we analyzed the combined risk effects of CHEK2∗1100delC and 77 common variants in terms of a polygenic risk score (PRS) and pairwise interaction.Results:The PRS conferr..
View full abstractGrants
Awarded by Seventh Framework Programme